FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF therapy for locally advanced esophageal carcinoma

被引：0
|
作者：
Yamamoto, S. [1 ]
Kato, K. [1 ]
Daiko, H. [2 ]
Kojima, T. [3 ]
Hara, H. [4 ]
Abe, T. [5 ]
Tsubosa, Y. [6 ]
Nagashima, K. [7 ]
Kitagawa, Y. [8 ]
机构：
[1] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
[3] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[4] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan
[5] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan
[6] Shizuoka Canc Ctr, Div Esophageal Surg, Shizuoka, Japan
[7] Inst Stat Math, Res Ctr Med & Hlth Data Sci, Tachikawa, Tokyo, Japan
[8] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
839TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF therapy for locally advanced esophageal carcinoma (JCOG1804E)-The short-term results of cohort A and B.
    Yamamoto, Shun
    Kato, Ken
    Daiko, Hiroyuki
    Kojima, Takashi
    Hara, Hiroki
    Abe, Tetsuya
    Tsubosa, Yasuhiro
    Kawakubo, Hirofumi
    Fujita, Takeo
    Fukuda, Takashi
    Kadowaki, Shigenori
    Tsushima, Takahiro
    Hamamoto, Yasuo
    Nagashima, Kengo
    Aoki, Kazunori
    Mizoguchi, Yukihiro
    Kitano, Shigehisa
    Yachida, Shinichi
    Shiba, Satoshi
    Kitagawa, Yuko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinoma (JCOG1804E)-Short-term results for cohorts C and D
    Matsuda, Satoru
    Yamamoto, Shun
    Kato, Ken
    Daiko, Hiroyuki
    Kojima, Takashi
    Hara, Hiroki
    Abe, Tetsuya
    Tsubosa, Yasuhiro
    Kawakubo, Hirofumi
    Nagashima, Kengo
    Aoki, Kazunori
    Yachida, Shinichi
    Kitagawa, Yuko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [3] FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinoma (JCOG1804E)-Primary safety and short-term efficacy results for cohort E.
    Yoshii, Takako
    Yamamoto, Shun
    Kato, Ken
    Daiko, Hiroyuki
    Hara, Hiroki
    Kojima, Takashi
    Abe, Tetsuya
    Tsubosa, Yasuhiro
    Kawakubo, Hirofumi
    Fujita, Takeo
    Kadowaki, Shigenori
    Tsushima, Takahiro
    Matsuda, Satoru
    Nagashima, Kengo
    Aoki, Kazunori
    Yachida, Shinichi
    Kitagawa, Yuko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 326 - 326
  • [4] Feasibility study of nivolumab as neoadjuvant chemotherapy for locally esophageal carcinoma: FRONTiER (JCOG1804E)
    Yamamoto, Shun
    Kato, Ken
    Daiko, Hiroyuki
    Kojima, Takashi
    Hara, Hiroki
    Abe, Tetsuya
    Tsubosa, Yasuhiro
    Nagashima, Kengo
    Aoki, Kazunori
    Mizoguchi, Yukihiro
    Kitano, Shigehisa
    Yachida, Shinichi
    Shiba, Satoshi
    Kitagawa, Yuko
    [J]. FUTURE ONCOLOGY, 2020, 16 (19) : 1351 - 1357
  • [5] Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
    Huang, Runkai
    Qiu, Zhenbin
    Zheng, Chunwen
    Zeng, Ruijie
    Chen, Wanxian
    Wang, Simeng
    Li, Enmin
    Xu, Yiwei
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).
    Yarchoan, Mark
    Zhu, Qingfeng
    Durham, Jennifer N.
    Gross, Nicole
    Charmsaz, Soren
    Leatherman, James M.
    Zhang, Shu
    Popovic, Aleksandra
    Weiss, Matthew John
    Philosophe, Benjamin
    Burkhart, Richard A.
    Burns, William
    Wilt, Brad
    Sugar, Elizabeth
    Fertig, Elana J.
    Laheru, Dan
    Anders, Robert A.
    Jaffee, Elizabeth M.
    Ho, Won Jin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [7] Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial
    Meng, Xiangrui
    Qi, Yu
    Shan, Zhengzheng
    Yang, Yang
    Fan, Qingxia
    Wang, Feng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Neoadjuvant chemo-immunotherapy still not as nice as neoadjuvant chemoradiation therapy for locally advanced esophageal carcinoma
    Rochefort, Matthew M.
    Wee, Jon O.
    [J]. JOURNAL OF THORACIC DISEASE, 2024, 16 (07) : 4829 - 4831
  • [9] Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
    Leng, Xue-Feng
    Daiko, Hiroyuki
    Han, Yong-Tao
    Mao, You-Sheng
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 213 - 224
  • [10] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Sasaki, Ken
    Uchikado, Yasuto
    Omoto, Itaru
    Arigami, Takaaki
    Osako, Yusaku
    Noda, Masahiro
    Okumura, Hiroshi
    Maemura, Kosei
    Higashi, Ryutaro
    Yoshiura, Takashi
    Natsugoe, Shoji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 581 - 587
12345